Freda C. Lewis-Hall, EVP, Medicines Development at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,250 shares at $29.11 ($36K) on 2009-03-19, disclosed to the SEC on 2009-03-20.
Scheduled sale ($36k) by EVP, Medicines Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2008-12-22 | $37K | — | Filing → |
| VRTX | SELL | 2008-12-12 | $33K | — | Filing → |